The onset of a sprue-like enteropathy in association with olmesartan therapy has been recently reported
Objective: To review the evidence of an association between olmesartan medoxomil and symptoms mimick...
Background/Aims Olmesartan, a widely used angiotensin II receptor blocker (ARB), has been linked to ...
Anti-hypertensive treatment with the angiotensin II receptor antagonist olmesartan is a rare cause o...
The onset of a sprue-like enteropathy in association with olmesartan therapy has been recently repor...
The recognition of an enteropathy caused by olmesartan is recent. It was first described in 2012 by ...
AbstractThe recognition of an enteropathy caused by olmesartan is recent. It was first described in ...
We are reporting a unique case of olmesartan associated severe sprue-like enteropathy in a 52-year-o...
Olmesartan-induced enteropathy is an underreported phenomenon, first described in 2012. While olmesa...
Objective: To review the evidence of an association between olmesartan medoxomil and symptoms mimick...
Background:Sprue-like enteropathy (SE) related to olmesartan use was first reported in 2012. In ...
Objective: To review the evidence of an association between olmesartan medoxomil and symptoms mimick...
AbstractChronic diarrhoea is a common clinical problem in gastroenterology practice and often it is ...
BACKGROUND: Recently, a new enteropathy has been described: olmesartan-associated enteropathy. Howev...
International audienceBACKGROUND: Recently, a new enteropathy has been described: olmesartan-associa...
Olmesartan, an angiotensin II receptor antagonist used to treat hypertension, is associated with few...
Objective: To review the evidence of an association between olmesartan medoxomil and symptoms mimick...
Background/Aims Olmesartan, a widely used angiotensin II receptor blocker (ARB), has been linked to ...
Anti-hypertensive treatment with the angiotensin II receptor antagonist olmesartan is a rare cause o...
The onset of a sprue-like enteropathy in association with olmesartan therapy has been recently repor...
The recognition of an enteropathy caused by olmesartan is recent. It was first described in 2012 by ...
AbstractThe recognition of an enteropathy caused by olmesartan is recent. It was first described in ...
We are reporting a unique case of olmesartan associated severe sprue-like enteropathy in a 52-year-o...
Olmesartan-induced enteropathy is an underreported phenomenon, first described in 2012. While olmesa...
Objective: To review the evidence of an association between olmesartan medoxomil and symptoms mimick...
Background:Sprue-like enteropathy (SE) related to olmesartan use was first reported in 2012. In ...
Objective: To review the evidence of an association between olmesartan medoxomil and symptoms mimick...
AbstractChronic diarrhoea is a common clinical problem in gastroenterology practice and often it is ...
BACKGROUND: Recently, a new enteropathy has been described: olmesartan-associated enteropathy. Howev...
International audienceBACKGROUND: Recently, a new enteropathy has been described: olmesartan-associa...
Olmesartan, an angiotensin II receptor antagonist used to treat hypertension, is associated with few...
Objective: To review the evidence of an association between olmesartan medoxomil and symptoms mimick...
Background/Aims Olmesartan, a widely used angiotensin II receptor blocker (ARB), has been linked to ...
Anti-hypertensive treatment with the angiotensin II receptor antagonist olmesartan is a rare cause o...
DOI
Add to ORKG